Davidson Jaime A, Kannel William B, Lopez-Candales Angel, Morales Leo, Moreno Pedro R, Ovalle Fernando, Rodriguez Carlos Jose, Rodbard Helena W, Rosenson Robert S, Stern Michael
University of Texas Southwestern Medical School, Dallas, TX, USA.
J Cardiometab Syndr. 2007 Fall;2(4):238-43. doi: 10.1111/j.1559-4564.2007.07534.x.
Cardiovascular disease (CVD) is the leading cause of death among the largest and fastest growing ethnic minority in the United States, Latinos/Hispanics. To review recent findings on the prevalence of CVD, CVD risk factors, and related illnesses in the US Latino/Hispanic population, an extensive PubMed and Internet literature search for studies published from January 1995 to July 2005 was conducted, using a combination of search terms. Data validity was assessed based on the quality of the source and a consensus of the authors on perceived validity. The review found limitations in current research as well as treatment methods and options for Latino/Hispanic persons at risk for developing CVD and related illnesses. Because of these limitations and the large public health concern, additional research is required to fully determine the best predictors of CVD and diabetes in Latino/Hispanic patients. A combined effort of health-influencing and health-governing bodies is needed on all levels to address the CVD problem in the Latino/Hispanic population.
心血管疾病（CVD）是美国最大且增长最快的少数族裔拉丁裔/西班牙裔人群的主要死因。为了回顾美国拉丁裔/西班牙裔人群中CVD患病率、CVD风险因素及相关疾病的最新研究结果，我们使用一系列搜索词，在PubMed和互联网上对1995年1月至2005年7月发表的研究进行了广泛检索。基于资料来源的质量以及作者们对可感知有效性的共识来评估数据的有效性。该综述发现了当前研究以及针对有患CVD及相关疾病风险的拉丁裔/西班牙裔人群的治疗方法和选项存在的局限性。由于这些局限性以及重大的公共卫生问题，需要开展更多研究以全面确定拉丁裔/西班牙裔患者中CVD和糖尿病的最佳预测因素。各级卫生影响机构和卫生管理机构需要共同努力，以解决拉丁裔/西班牙裔人群中的CVD问题。
